Cargando…
SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020
The outbreak of coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China, in December 2019. To investigate the prevalence of COVID-19 in Wuhan, we conducted serologic tests on 35,326 individuals from four different communities to estimate cumulative incidence of infection. Our results...
Autores principales: | Han, Huan, Yi, Junzhu, Cheng, Gongbo, Jiang, Wuhui, Brożek, Grzegorz M., Jiang, Yingan, Zhu, Chengliang, Xia, Yuchen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546712/ https://www.ncbi.nlm.nih.gov/pubmed/33883260 http://dx.doi.org/10.1128/mSphere.01062-20 |
Ejemplares similares
-
Environmental surveillance of SARS-CoV-2 RNA in wastewater systems and related environments in Wuhan: April to May of 2020
por: Zhao, Lu, et al.
Publicado: (2022) -
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020
por: Biggs, Holly M., et al.
Publicado: (2020) -
Seroprevalence of SARS-CoV-2 antibodies in Seattle, Washington: October 2019–April 2020
por: McCulloch, Denise J., et al.
Publicado: (2021) -
Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020
por: Shakiba, Maryam, et al.
Publicado: (2021) -
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
por: Capai, Lisandru, et al.
Publicado: (2020)